Malignant Histiocytic Disorders

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2025-09-18
Clinical Trial Update: Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders [Phase 2]
Phase 2 clinical trial update evaluating cobimetinib in refractory Langerhans cell histiocytosis and other histiocytic disorders, currently …